Bringing you the Best Analytical Legal News
This column will provide all information related to Law Firms.
Shardul Amarchand Mangaldas advised Tata Steel Limited on its strategic acquisition of a 50.01% stake in Thriveni Pellets Private Limited, strengthening Tata Steel’s long-term value creation strategy.
Continue reading
The transaction grants Saregama a significant minority equity stake in Bhansali Productions along with exclusive music rights for all future Bhansali films.
Continue reading
SAM advised the CoCs of three Arshiya Group entities in an NCLAT-approved multi-CIRP asset sale ensuring operational continuity and value maximisation.
Continue reading
CAM advises Swiggy Limited on its ₹10,000 crore QIP, one of India’s largest consumer-tech equity offerings and the second-largest non-banking QIP.
Continue reading
The investment, announced on November 25, was made by funds managed by KKR along with participation from new investor PSP Investments of Canada, reinforcing confidence in India’s education sector.
Continue reading
The transaction strengthens Lighthouse Learning’s position as a leading Indian education services provider. CAM advised on corporate, diligence, real estate, employment, disputes, finance, and competition aspects of the deal.
Continue reading
The deal forms part of Wakefit’s broader pre-IPO fundraising ahead of its proposed public listing. SAM advised on transaction, regulatory and tax aspects.
Continue reading
SAM advised Meesho on the fresh issue, offer for sale, and securities regulatory aspects through a multidisciplinary capital markets team.
Continue reading
SAM supported the transaction end-to-end, including structuring, diligence, competition, and regulatory aspects. The deal involved multi-team coordination across M&A, private equity, competition, and regulatory practices.
Continue reading
Shardul Amarchand Mangaldas advised Biocon Limited on its ~USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics from multiple investors.
Continue reading
The transaction marks the first phase of consolidating L&T’s real estate assets into a unified entity positioned for India’s growing property market.
Continue reading
The firm advised prominent investors such as Elevation Capital, Peak Investments, Venture Highway, and Y Combinator. The issue opened on December 3 and closed on December 5, 2025.
Continue reading
Khaitan & Co appoints Dr. Vimal Choudhary as Chief Operating Officer, bringing over 23 years of global consulting and strategy experience to drive the Firm’s growth and digital transformation.
Continue reading
Cyril Amarchand Mangaldas advised Sheela Foam Limited on further investment in Furlenco via preferential issue and structuring investor rights in the funding round.
Continue reading
Lakshmikumaran & Sridharan advised Sai Parenteral’s Limited and its Singapore arm on the cross-border acquisition of 74.6% stake in Noumed Pharmaceuticals Pty Ltd, Australia.
Continue reading
Cyril Amarchand Mangaldas advised Serum Institute on the proposed sale of its stake in Biocon Biologics to Biocon and the simultaneous subscription of shares in Biocon Limited through a share swap transaction valued at ₹2,250 crore. The deal marks a significant restructuring in India’s biopharmaceutical sector.
Continue reading
Khaitan & Co advised Viatris on the USD 815 million sale of its stake in Biocon Biologics to Biocon via cash payment and preferential share allotment.
Continue reading
Fox & Mandal successfully defended Shalimar before the Calcutta High Court in a passing-off action, securing protection for its distinctive trade dress and packaging.
Continue reading
Cyril Amarchand Mangaldas advised Swiss Parenterals Limited and its promoter on the sale of the remaining 30% stake to Eris Lifesciences Limited through a preferential allotment deal worth ₹423.30 crore.
Continue reading
Framework to provide structured resolution for delay & disruption claims in India
Continue reading